日本-话题@MedSci

#日本#

594篇内容 | 8325人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294595, encodeId=33eb12945956e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？, objectType=article, longId=205875, objectId=ec732058e5cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec732058e5cb, replyNumber=0, likeNumber=63, createdTime=2021-01-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec732058e5cb, moduleTitle=日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec732058e5cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294594, encodeId=604d129459411, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=又一国！日本发现新型变异新冠病毒, objectType=article, longId=205649, objectId=a13920564985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13920564985, replyNumber=0, likeNumber=52, createdTime=2021-01-13, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13920564985, moduleTitle=又一国！日本发现新型变异新冠病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a13920564985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294593, encodeId=d1c01294593ca, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2021年1月11日全球新冠肺炎（COVID-19）疫情简报，确诊超9065万，新冠在日本又出现新的突变, objectType=article, longId=205627, objectId=328f20562e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=328f20562e54, replyNumber=0, likeNumber=94, createdTime=2021-01-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=328f20562e54, moduleTitle=2021年1月11日全球新冠肺炎（COVID-19）疫情简报，确诊超9065万，新冠在日本又出现新的突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=328f20562e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294592, encodeId=322012945927f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Lynparza在日本获准用于治疗晚期卵巢癌、前列腺癌和胰腺癌, objectType=article, longId=205138, objectId=363b20513825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=363b20513825, replyNumber=0, likeNumber=64, createdTime=2021-01-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=363b20513825, moduleTitle=Lynparza在日本获准用于治疗晚期卵巢癌、前列腺癌和胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=363b20513825)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294591, encodeId=2ad71294591b4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本通过《预防接种法》民众可免费接种新冠疫苗, objectType=article, longId=204061, objectId=0ccd20406140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ccd20406140, replyNumber=0, likeNumber=65, createdTime=2020-12-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ccd20406140, moduleTitle=日本通过《预防接种法》民众可免费接种新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ccd20406140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294590, encodeId=8e6a129459069, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=JNNP:抗MOG抗体相关疾病——日本和德国临床特征和预后的差异, objectType=article, longId=203912, objectId=89e5203912cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89e5203912cb, replyNumber=0, likeNumber=80, createdTime=2020-12-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89e5203912cb, moduleTitle=JNNP:抗MOG抗体相关疾病——日本和德国临床特征和预后的差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89e5203912cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294589, encodeId=69e3129458966, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Acta Neuropathologica: 食管路易病理学与路易体病进展的相关性：日本尸检病例队列研究, objectType=article, longId=203904, objectId=a3cf2039048d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3cf2039048d, replyNumber=0, likeNumber=66, createdTime=2020-12-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3cf2039048d, moduleTitle=Acta Neuropathologica: 食管路易病理学与路易体病进展的相关性：日本尸检病例队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3cf2039048d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294588, encodeId=e212129458869, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本制药公司Sosei Heptares发现或可治疗COVID-19的小分子, objectType=article, longId=203880, objectId=b33b203880a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b33b203880a7, replyNumber=0, likeNumber=69, createdTime=2020-12-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b33b203880a7, moduleTitle=日本制药公司Sosei Heptares发现或可治疗COVID-19的小分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b33b203880a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294587, encodeId=eaab129458e7d, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Nature：日本和柬埔寨发现与新冠密切相关的冠状病毒！, objectType=article, longId=203743, objectId=b9c3203e4396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9c3203e4396, replyNumber=0, likeNumber=70, createdTime=2020-11-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9c3203e4396, moduleTitle=Nature：日本和柬埔寨发现与新冠密切相关的冠状病毒！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9c3203e4396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294586, encodeId=1dd212945864b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究, objectType=article, longId=203356, objectId=48e320335672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48e320335672, replyNumber=0, likeNumber=54, createdTime=2020-11-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48e320335672, moduleTitle=Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48e320335672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294585, encodeId=cd6012945858f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本单中心下肢腔内介入治疗10年临床结果发布, objectType=article, longId=202739, objectId=cc6a202e39e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6a202e39e9, replyNumber=0, likeNumber=73, createdTime=2020-11-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6a202e39e9, moduleTitle=日本单中心下肢腔内介入治疗10年临床结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6a202e39e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294584, encodeId=a7fe1294584a3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本人血液中这种有害物质超标！疑是美军“投毒”？, objectType=article, longId=202691, objectId=4113202691b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4113202691b4, replyNumber=0, likeNumber=65, createdTime=2020-11-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4113202691b4, moduleTitle=日本人血液中这种有害物质超标！疑是美军“投毒”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4113202691b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294583, encodeId=03da1294583c0, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=BMJ Open Diabetes Res Care：日本学者揭示：多喝绿茶和咖啡，可显著降低糖尿病患者死亡风险, objectType=article, longId=202619, objectId=224b202619f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=224b202619f7, replyNumber=0, likeNumber=112, createdTime=2020-10-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=224b202619f7, moduleTitle=BMJ Open Diabetes Res Care：日本学者揭示：多喝绿茶和咖啡，可显著降低糖尿病患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=224b202619f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294582, encodeId=64621294582ba, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=拍一拍脖子竟然瘫痪了？这种“日本病”，切勿随意按压！, objectType=article, longId=201920, objectId=9d0a20192052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d0a20192052, replyNumber=0, likeNumber=64, createdTime=2020-10-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d0a20192052, moduleTitle=拍一拍脖子竟然瘫痪了？这种“日本病”，切勿随意按压！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d0a20192052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294581, encodeId=2e8d129458169, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好, objectType=article, longId=201761, objectId=5d9d201e6149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d9d201e6149, replyNumber=0, likeNumber=69, createdTime=2020-10-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d9d201e6149, moduleTitle=Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d9d201e6149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294580, encodeId=45e61294580e3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本政府决定免费为国民接种新冠疫苗, objectType=article, longId=201607, objectId=318a20160e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=318a20160e78, replyNumber=0, likeNumber=56, createdTime=2020-10-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=318a20160e78, moduleTitle=日本政府决定免费为国民接种新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=318a20160e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294579, encodeId=4ca912945e9c3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=J Gastroenterol：日本的诊断标准可以在某些患者发展为慢性胰腺炎之前对其进行识别, objectType=article, longId=201288, objectId=319820128868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=319820128868, replyNumber=0, likeNumber=78, createdTime=2020-09-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=319820128868, moduleTitle=J Gastroenterol：日本的诊断标准可以在某些患者发展为慢性胰腺炎之前对其进行识别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=319820128868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294578, encodeId=b3ff12945e8b3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准, objectType=article, longId=201256, objectId=8539201256b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8539201256b5, replyNumber=0, likeNumber=65, createdTime=2020-09-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8539201256b5, moduleTitle=Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8539201256b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294577, encodeId=0f1f12945e7c3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省批准ravulizumab治疗成人和儿童非典型溶血性尿毒症综合征（aHUS）, objectType=article, longId=201254, objectId=80e12012542c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e12012542c, replyNumber=0, likeNumber=75, createdTime=2020-09-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e12012542c, moduleTitle=日本厚生劳动省批准ravulizumab治疗成人和儿童非典型溶血性尿毒症综合征（aHUS）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e12012542c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294576, encodeId=302b12945e631, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本用干细胞培育出迷你心脏，未来“人造器官”不是梦, objectType=article, longId=201229, objectId=2f172012297e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f172012297e, replyNumber=0, likeNumber=85, createdTime=2020-09-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f172012297e, moduleTitle=日本用干细胞培育出迷你心脏，未来“人造器官”不是梦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f172012297e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

日本胃癌五年生存率高达80%，我国只有30%，为什么差距这么大？

2021-01-20

智智灵药 (审核中...)

前往app查看评论内容

#日本#

又一国！日本发现新型变异新冠病毒

2021-01-13

chentianping (审核中...)

前往app查看评论内容

#日本#

2021年1月11日全球新冠肺炎（COVID-19）疫情简报，确诊超9065万，新冠在日本又出现新的突变

2021-01-12

chentianping (审核中...)

前往app查看评论内容

#日本#

Lynparza在日本获准用于治疗晚期卵巢癌、前列腺癌和胰腺癌

2021-01-02

chentianping (审核中...)

前往app查看评论内容

#日本#

日本通过《预防接种法》民众可免费接种新冠疫苗

2020-12-04

chentianping (审核中...)

前往app查看评论内容

#日本#

JNNP:抗MOG抗体相关疾病——日本和德国临床特征和预后的差异

2020-12-01

chentianping (审核中...)

前往app查看评论内容

#日本#

Acta Neuropathologica: 食管路易病理学与路易体病进展的相关性：日本尸检病例队列研究

2020-12-01

chentianping (审核中...)

前往app查看评论内容

#日本#

日本制药公司Sosei Heptares发现或可治疗COVID-19的小分子

2020-12-01

chentianping (审核中...)

前往app查看评论内容

#日本#

Nature：日本和柬埔寨发现与新冠密切相关的冠状病毒！

2020-11-27

chentianping (审核中...)

前往app查看评论内容

#日本#

Int J Clin Oncol：研究肯定pertuzumab在日本患者中的疗效，支持其在日本患者人群中的继续研究

2020-11-15

chentianping (审核中...)

前往app查看评论内容

#日本#

日本单中心下肢腔内介入治疗10年临床结果发布

2020-11-02

chentianping (审核中...)

前往app查看评论内容

#日本#

日本人血液中这种有害物质超标！疑是美军“投毒”？

2020-11-01

chentianping (审核中...)

前往app查看评论内容

#日本#

BMJ Open Diabetes Res Care：日本学者揭示：多喝绿茶和咖啡，可显著降低糖尿病患者死亡风险

2020-10-31

chentianping (审核中...)

前往app查看评论内容

#日本#

拍一拍脖子竟然瘫痪了？这种“日本病”，切勿随意按压！

2020-10-11

chentianping (审核中...)

前往app查看评论内容

#日本#

Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好

2020-10-07

chentianping (审核中...)

前往app查看评论内容

#日本#

日本政府决定免费为国民接种新冠疫苗

2020-10-05

chentianping (审核中...)

前往app查看评论内容

#日本#

J Gastroenterol：日本的诊断标准可以在某些患者发展为慢性胰腺炎之前对其进行识别

2020-09-28

chentianping (审核中...)

前往app查看评论内容

#日本#

Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准

2020-09-28

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省批准ravulizumab治疗成人和儿童非典型溶血性尿毒症综合征（aHUS）

2020-09-28

chentianping (审核中...)

前往app查看评论内容

#日本#

日本用干细胞培育出迷你心脏，未来“人造器官”不是梦

2020-09-27

科室
- - 订阅+
  - 更多科室
工具
服务